Clinically Significant Drug Interactions with New Immunosuppressive Agents

被引：0
作者：
Christian Mignat
机构：
[1] Christian Albrechts University of Kiel,Department of Pharmacology
来源：
Drug Safety | 1997年 / 16卷
关键词：
Adis International Limited; Tacrolimus; Sirolimus; Mycophenolate Mofetil; Danazol;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Tacrolimus (FK506), mycophenolate mofetil, sirolimus (rapamycin), gusperimus, and monoclonal antibody preparations are new immunosuppressive agents, some of which are already approved for clinical use, while others are currently undergoing clinical trials. The present article provides an overview of adverse drug interactions between these immunosuppressants and other drugs which may be used concomitantly.
引用
收藏
页码：267 / 278
页数：11
相关论文
共 147 条
[71]  
Shah IA(undefined)undefined undefined undefined undefined-undefined
[72]  
Thomson AW(undefined)undefined undefined undefined undefined-undefined
[73]  
Starzl TE(undefined)undefined undefined undefined undefined-undefined
[74]  
Todo S(undefined)undefined undefined undefined undefined-undefined
[75]  
Fung J(undefined)undefined undefined undefined undefined-undefined
[76]  
Jain AB(undefined)undefined undefined undefined undefined-undefined
[77]  
Venkataramanan R(undefined)undefined undefined undefined undefined-undefined
[78]  
Fung J(undefined)undefined undefined undefined undefined-undefined
[79]  
McCauley J(undefined)undefined undefined undefined undefined-undefined
[80]  
Takaya S(undefined)undefined undefined undefined undefined-undefined
3456789101112